XBiotech Successfully Clones First Anti-Ebola Therapeutic Antibody Product Candidate

By: via Benzinga
XBiotech (Nasdaq: XBIT), the developer of True Human™ therapeutic antibodies, announced today that it has successfully isolated and ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.